VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EQH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EQHEquitable Holdings, Inc.
$46.98$13.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEQHQuarterly Financials

Equitable Holdings, Inc. (EQH) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Equitable Holdings, Inc. (EQH) quarterly income statement — complete revenue, gross profit & net income history

EQH Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue4.23B3.28B1.45B2.36B3.9B3.62B2.98B3.51B2.23B2.17B3.62B2.38B2.36B1.9B2.99B4.69B3.15B3.32B3.62B2.95B
Revenue Growth %8.35%-9.5%-51.28%-32.65%75.07%66.87%-17.88%47.54%-5.39%14.45%21.12%-49.32%-25.08%-42.86%-17.23%58.98%172.85%543.02%96.47%215.69%
Medical Costs & Claims394M391M1.7B1.65B757M1.19B662M1.76B782M1.78B1.05B751M1.75B1.67B1.05B2.26B1.24B1.6B1.56B1.64B
Medical Cost Ratio %9.31%11.93%116.97%69.64%19.39%32.75%22.24%50.16%35.07%82.26%29%31.59%74.2%88.19%35.16%48.27%39.26%48.13%43.04%55.59%
Gross Profit3.84B2.89B-246M717M3.15B2.44B2.31B1.75B1.45B385M2.57B1.63B608M224M1.94B2.43B1.91B1.72B2.06B1.31B
Gross Margin %90.69%88.07%-16.97%30.36%80.61%67.25%77.76%49.84%64.93%17.74%71%68.41%25.8%11.81%64.84%51.73%60.74%51.87%56.96%44.41%
Gross Profit Growth %21.89%18.52%-110.63%-58.98%117.33%532.47%-10.07%7.5%138.16%71.88%32.63%-32.98%-68.18%-86.98%-5.78%85.19%450%275.08%2927.94%132.29%
Operating Expenses2.95B2.54B1.1B1.08B2.97B1.24B2.33B1.07B1.23B1.2B1.1B1.09B1.07B1.15B1.11B1.15B1.18B1.26B1.13B1.07B
OpEx / Revenue %69.72%77.57%76%45.72%76.15%34.19%78.13%30.42%55.11%55.39%30.3%45.73%45.27%60.39%37.27%24.54%37.41%37.85%31.23%36.14%
Depreciation & Amortization224M220M219M220M213M220M212M193M241M236M196M156M224M227M213M36M142M161M88M95M
Combined Ratio %79.03%89.5%192.97%115.37%95.54%66.94%100.37%80.58%90.18%137.65%59.3%77.32%119.47%148.58%72.43%72.81%76.67%85.99%74.27%91.73%
Operating Income887M344M-1.35B-363M174M1.2B-11M681M219M-817M1.48B539M-459M-921M825M1.27B734M465M930M244M
Operating Margin %20.97%10.5%-92.97%-15.37%4.46%33.06%-0.37%19.42%9.82%-37.65%40.7%22.68%-19.47%-48.58%27.57%27.19%23.33%14.01%25.73%8.27%
Operating Income Growth %409.77%-71.26%-12154.55%-153.3%-20.55%246.51%-100.75%26.35%147.71%11.29%78.79%-57.73%-162.53%-298.06%-11.29%422.54%140.6%123.01%200.76%104.87%
EBITDA1.11B564M-1.13B-143M387M1.42B201M874M460M-581M1.67B695M-235M-694M1.04B1.31B876M626M1.02B339M
EBITDA Margin %26.26%17.21%-77.86%-6.05%9.91%39.13%6.75%24.92%20.63%-26.77%46.11%29.24%-9.97%-36.6%34.69%27.95%27.84%18.87%28.16%11.49%
Interest Expense62M47M61M61M55M52M55M62M57M57M55M55M61M53M51M50M47M60M59M51M
Non-Operating Income-62M-47M-61M-61M-55M-52M-55M-62M-57M-57M-55M-55M-61M-53M-51M-50M-47M-60M-59M-51M
Pretax Income887M344M-1.35B-363M174M1.2B-11M681M219M-817M1.48B539M-459M-921M825M1.27B734M465M930M244M
Pretax Margin %20.97%10.5%-92.97%-15.37%4.46%33.06%-0.37%19.42%9.82%-37.65%40.7%22.68%-19.47%-48.58%27.57%27.19%23.33%14.01%25.73%8.27%
Income Tax156M33M-133M-80M24M182M-39M116M24M-228M340M-292M-725M-208M177M264M137M77M165M21M
Effective Tax Rate %17.59%9.59%9.87%22.04%13.79%15.2%354.55%17.03%10.96%27.91%23.05%-54.17%157.95%22.58%21.45%20.71%18.66%16.56%17.74%8.61%
Net Income621M215M-1.31B-349M63M899M-132M428M92M-698M1.06B759M177M-789M594M967M530M254M672M123M
Net Margin %14.68%6.56%-90.28%-14.78%1.61%24.83%-4.44%12.2%4.13%-32.17%29.36%31.93%7.51%-41.61%19.85%20.62%16.85%7.66%18.59%4.17%
Net Income Growth %885.71%-76.08%-891.67%-181.54%-31.52%228.8%-112.41%-43.61%-48.02%11.53%79.12%-21.51%-66.6%-410.63%-11.61%686.18%135.62%120.52%186.26%103.06%
EPS (Diluted)2.140.70-4.47-1.210.162.76-0.461.230.23-2.153.022.060.450.100.694.471.320.561.590.23
EPS Growth %1237.5%-74.64%-871.74%-198.37%-30.43%228.37%-115.23%-40.29%-48.89%-2300.61%337.68%-53.91%-65.91%-82.55%-56.6%1843.48%138.15%119.72%189.83%102.57%
EPS (Basic)2.160.71-4.47-1.210.162.80-0.461.240.24-2.153.032.060.450.100.694.491.330.571.600.23
Diluted Shares Outstanding283.8M289.1M303.2M303.2M311.9M316.5M318.2M327.3M332.7M337.2M348M356.1M364.1M371.5M376.8M380.6M391.7M404.3M414.6M428.3M